Physical Activity and Ventricular Arrhythmias
1 other identifier
interventional
55
1 country
1
Brief Summary
The purpose of the study is to determine the effect of aerobic interval training in patients with an implantable cardioverter defibrillator (ICD) on physical fitness, quality of life and the amount of serious ventricular arrhythmic events on short and long term.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2019
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 21, 2019
CompletedFirst Posted
Study publicly available on registry
August 28, 2019
CompletedStudy Start
First participant enrolled
September 2, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 2, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
September 2, 2022
CompletedApril 26, 2023
April 1, 2023
3 years
August 21, 2019
April 25, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change in physical fitness/aerobic capacity
Expressed in and measured with maximal oxygen uptake (VO2 peak)
Change from baseline and after ended intervention period (12 weeks)
Change in assessment of quality of life
Patient-reported survey of patient health SF-36
Change from baseline and after intervention period (12 weeks)
Secondary Outcomes (20)
Change in burden of ventricular arrhythmias from baseline to week 9-12
Baseline and the last 4 weeks of intervention period (week 9-12)
Change in burden of ventricular arrhythmias from baseline to week 13-16
Baseline and the first 4 weeks after intervention period (week 13-16)
Change in burden of ventricular arrhythmias from baseline to week 9-16
Baseline and the last 4 weeks of intervention period plus 4 first weeks after intervention period (week 9-16)
Change in burden of ventricular arrhythmias from baseline to week 9-12
Baseline and the last 4 weeks of intervention period (week 9-12)
Change in burden of ventricular arrhythmias from baseline to week 13-16
Baseline and the first 4 weeks after intervention period (week 13-16)
- +15 more secondary outcomes
Study Arms (2)
Interval training group
EXPERIMENTALAerobic interval training during 12 weeks 3 times a week.
Control group
NO INTERVENTIONNo lifestyle recommendations. Usual daily life.
Interventions
Aerobic interval training during 12 weeks 3 times a week: 4 x 4 minutes intervals at an intensity of 90-95% of VO2 peak and active breaks of 3 minutes between intervals.
Eligibility Criteria
You may qualify if:
- Patients with ICD and dilated cardiomyopathy or coronary heart disease as cause for implantation
- ICD implanted at St Olavs hospital, Trondheim
You may not qualify if:
- inability to accomplish the exercise program due to serious comorbidity or to participate in regular training within the next 3 months due to other reasons
- signs of severe cardiac ischemia or persistent ventricular tachycardia during individualized treadmill O2 peak test, which after individual assessment is to be found at risk
- comorbidity where endurance training at more than moderate intensity is discouraged
- severe cardiac valve disease
- planned surgery within the next 3 months
- inability to give informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- St. Olavs Hospitallead
- Norwegian University of Science and Technologycollaborator
Study Sites (1)
St Olavs Hospital
Trondheim, Norway
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Rune Wiseth, MD, Prof
St. Olavs Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 21, 2019
First Posted
August 28, 2019
Study Start
September 2, 2019
Primary Completion
September 2, 2022
Study Completion
September 2, 2022
Last Updated
April 26, 2023
Record last verified: 2023-04
Data Sharing
- IPD Sharing
- Will share
- Time Frame
- After publication
- Access Criteria
- Not yet decided
Individual participant data for all primary and secondary outcome measures will be made available after deidentification and publication